RxDoctor Payments Data

Franklin Moore, MD

Anatomic Pathology & Clinical Pathology · Springfield, MANPI 1174702864

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $36,690 of the $49,751 with a category attached, or 73.7%. AstraZeneca accounts for 98.3% of it on its own, with 2 other manufacturers making up the rest. Reporting peaked in 2019 at $38,912 and has fallen 100.0% since, to $16 in 2024. Among anatomic pathology & clinical pathology clinicians in MA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$49,751in general payments, 2019–2025

Across 33 payments — averaging $1507.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$49K
  • Roche Sequencing Solutions, Inc.$800
  • Biofire Diagnostics, LLC$40
$975in research payments, 2019–2025

Across 1 payment — averaging $975.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Genmark Diagnostics, Inc.$975

What the payments were for

  • Consulting fees$9,98320%
  • Speaking & faculty fees$36,69074%
  • Travel & lodging$2,4165%
  • Food & beverage$6621%

General payments by program year

19
20
21
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$49,751 in reported general payments places this provider in the 95th percentile of 196 anatomic pathology & clinical pathology providers in Massachusetts.

See all anatomic pathology & clinical pathology providers in Massachusetts

Medicare billing

Part B allowed, 2024
$28,055
Medicare patients
407
Services billed
611

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other anatomic pathology & clinical pathology in Springfield

See the full list for Massachusetts

Where these figures come from

Is this you, or does something look wrong? →